VBI VACCINES INC.
DelistedCIK 704159fmd_1MM664SRP0GRTMKCFG5MSES46EManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2010 to Dec 31, 2015, 23 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|---|
| Total revenues | 18 | 15 | 8 | 11 | – | 0 |
| Trading and principal transactions revenue | 0 | (1) | 1 | 1 | – | – |
| Commissions and fees | 16 | 15 | 4 | 3 | – | – |
| Research and development | – | – | – | 1 | 3 | 7 |
| Selling, general and administrative | 20 | 19 | – | – | – | – |
| Compensation and benefits | 16 | 15 | 5 | 5 | – | – |
| Total operating expenses | – | 19 | 8 | 12 | 13 | 14 |
| Operating income | – | – | – | – | (13) | (13) |
| Interest expense | – | – | – | 2 | 1 | 0 |
| Interest and investment income | 0 | 1 | 1 | 0 | 0 | 0 |
| Income tax expense | (0) | (0) | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (1) | (3) | – | (4) | (13) | – |
| Net income | (1) | (3) | (0) | (5) | (14) | (14) |
| Net income to common shareholders | – | – | (0) | (2) | – | – |